Comparing the Clinical and Economic Outcomes Associated with Adjuvanted versus High-Dose Trivalent Influenza Vaccine among Adults Aged ≥ 65 Years in the US during the 2019–20 Influenza Season—A Retrospective Cohort Analysis

The burden of influenza is disproportionally higher among older adults. We evaluated the relative vaccine effectiveness (rVE) of adjuvanted trivalent (aIIV3) compared to high-dose trivalent influenza vaccine (HD-IIV3e) against influenza and cardio-respiratory disease (CRD)-related hospitalizations/E...

Descripción completa

Detalles Bibliográficos
Autores principales: Levin, Myron J., Divino, Victoria, Shah, Drishti, DeKoven, Mitch, Mould-Quevedo, Joaquin, Pelton, Stephen I., Postma, Maarten J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540032/
https://www.ncbi.nlm.nih.gov/pubmed/34696254
http://dx.doi.org/10.3390/vaccines9101146

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540032/
https://www.ncbi.nlm.nih.gov/pubmed/34696254
http://dx.doi.org/10.3390/vaccines9101146

Ejemplares similares